Edwards Lifesciences (Irvine, California) reported the first implant of its Carpentier-Edwards Perimount Magna replacement tissue heart valve that also features its newly approved ThermaFix tissue process, which is designed to greatly reduce tissue valve calcification.(Product Pipeline)(Brief Article)

Edwards Lifesciences (Irvine, California) reported the first implant of its Carpentier-Edwards Perimount Magna replacement tissue heart valve that also features its newly approved ThermaFix tissue process, which is designed to greatly reduce tissue valve calcification. The procedure was performed by Delos Cosgrove, MD, chairman of the department of thoracic and cardiovascular surgery at the Cleveland Clinic Foundation (Cleveland, Ohio). The Perimount is an aortic replacement tissue heart valve constructed of bovine pericardium that was specifically designed to optimize patient blood flow. The device was cleared for sale by the FDA last November. The Magna was designed to replace …